CD274 and neoplasm: Therefore, comprehensive and dynamic evaluation of both the global PD-L1 level and IFN expression on T-cells and tumor cells, rather than monitoring only surface PD-L1 on tumor cells, should be a more effective approach for predicting responses to ICB.